OSCR

Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing.

Overview

Authors: Yuxuan Kong1,2, Yingjie Zhang1,2, Erjie Xie1, Xiao Li1,2, Zhuoxi Peng2, Jingyuan Zhang2, Yu Zhao1, Huijun Yuan1,2
  1. Department of Otorhinolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University,Chengdu, 610041 China
  2. Institute of Rare Diseases, West China Hospital, Sichuan University,Chengdu, 610000 China
Institutions: Sichuan University (China)
Journal: EMBO molecular medicine, volume 18, issue 6, pages 2293-2321
Dates: received 13 September 2025; accepted 13 April 2026; published online 20 May 2026; in print June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s44321-026-00433-5 · PMID 42162447 · PMCID PMC13270111 · OpenAlex W7161830275
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), mouse (organism), other condition (population)
Methods: Statistics
Keywords: Genetics, Gene Therapy & Genetic Disease
MeSH: Adenine*, Gene Editing*, Genetic Therapy*, Hearing Loss*, Hearing Loss, Sensorineural*, KCNQ Potassium Channels*, Animals, Disease Models, Animal, Evoked Potentials, Auditory, Brain Stem, Gene Knock-In Techniques, Gene Therapy Agents, Humans, Mice (* major topic)
Topic: CRISPR and Genetic Engineering (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: National Natural Science Foundation of China (82030030, 82530036); 1.3.5 Project for Disciplines of Excellence, West China Hospital (ZYJC20002)
Citations: not cited yet (Europe PMC); 112 references in the paper

Abstract

Hereditary hearing loss, the most prevalent genetic sensory disorder, lacks approved pharmacological therapies and represents a compelling target for gene correction. Pathogenic variants in KCNQ4 account for ~9.5% of autosomal dominant nonsyndromic cases. Prior gene-editing strategies disrupting mutant alleles have failed to achieve durable auditory rescue. Here we employed a knock-in mouse model harboring the human KCNQ4 c.961 G > A (p.G321S) mutation to evaluate precise base editing. Dual-AAV delivery of the adenine base editor ABE8e achieved 21.4–28.9% correction in the organ of Corti—the highest efficiency reported for genetic hearing loss. A dose-dependent therapeutic window emerged: higher doses promoted rapid recovery, whereas optimized lower doses minimized long-term toxicity and sustained functional benefit for at least 32 weeks. Treatment reduced auditory brainstem response thresholds by up to 49.09 dB SPL at optimal frequencies, mitigated degeneration of hair cells, spiral ganglion neurons, and auditory nerve fibers, and partially restored outer hair cell electrophysiology. These findings demonstrate the durability of precise mutation correction over allele-disruptive approaches and support clinical translation for KCNQ4-associated hearing loss.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

Data availability

The datasets produced in this study are available in the following database: Amplicon sequencing, RNA-seq and GUIDE-seq data: the NCBI sequence read archive PRJNA1420045.

The source data of this paper are collected in the following database record: biostudies:S-SCDT-10_1038-S44321-026-00433-5 (https://www.ebi.ac.uk/biostudies/sourcedata/studies/S-SCDT-10_1038-S44321-026-00433-5).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 1 keyword, 13 MeSH terms, 2 funders, 109 references.

Cite

This paper

Kong, Y., Zhang, Y., Xie, E., Li, X., Peng, Z., Zhang, J., Zhao, Y., & Yuan, H. (2026). Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing. EMBO molecular medicine, 18(6), 2293-2321. https://doi.org/10.1038/s44321-026-00433-5

BibTeX

@article{kong2026long,
author = {Kong, Yuxuan and Zhang, Yingjie and Xie, Erjie and Li, Xiao and Peng, Zhuoxi and Zhang, Jingyuan and Zhao, Yu and Yuan, Huijun},
title = {{Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing}},
journal = {EMBO molecular medicine},
year = {2026},
month = may,
volume = {18},
number = {6},
pages = {2293--2321},
publisher = {Nature Publishing Group},
issn = {1757-4676},
doi = {10.1038/s44321-026-00433-5},
url = {https://doi.org/10.1038/s44321-026-00433-5},
pmid = {42162447},
pmcid = {PMC13270111}
}

RIS

TY - JOUR
AU - Kong, Yuxuan
AU - Zhang, Yingjie
AU - Xie, Erjie
AU - Li, Xiao
AU - Peng, Zhuoxi
AU - Zhang, Jingyuan
AU - Zhao, Yu
AU - Yuan, Huijun
TI - Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing
T2 - EMBO molecular medicine
J2 - EMBO Mol Med
PY - 2026
DA - 2026/05/20
VL - 18
IS - 6
SP - 2293
EP - 2321
SN - 1757-4676
PB - Nature Publishing Group
DO - 10.1038/s44321-026-00433-5
UR - https://doi.org/10.1038/s44321-026-00433-5
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s44321-026-00433-5",
"type": "article-journal",
"title": "Long-term restoration of auditory function in a DFNA2 mouse model by adenine base editing",
"container-title": "EMBO molecular medicine",
"author": [
{
"family": "Kong",
"given": "Yuxuan"
},
{
"family": "Zhang",
"given": "Yingjie"
},
{
"family": "Xie",
"given": "Erjie"
},
{
"family": "Li",
"given": "Xiao"
},
{
"family": "Peng",
"given": "Zhuoxi"
},
{
"family": "Zhang",
"given": "Jingyuan"
},
{
"family": "Zhao",
"given": "Yu"
},
{
"family": "Yuan",
"given": "Huijun"
}
],
"container-title-short": "EMBO Mol Med",
"volume": "18",
"issue": "6",
"page": "2293-2321",
"DOI": "10.1038/s44321-026-00433-5",
"PMID": "42162447",
"PMCID": "PMC13270111",
"ISSN": "1757-4676",
"publisher": "Nature Publishing Group",
"URL": "https://doi.org/10.1038/s44321-026-00433-5",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
20
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-024-55275-x [code]
Defects in hair cells disrupt the development of auditory peripheral circuitry.
Journal: Nature communications
In common: other condition, mouse, 8 references
[2] doi:10.1016/j.ymthe.2025.03.057
Current trends in gene therapy to treat inherited disorders of the brain.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: 9 references
[3] doi:10.1016/j.cell.2025.06.038
In vivo prime editing rescues alternating hemiplegia of childhood in mice.
Journal: Cell
In common: mouse, 8 references
[4] doi:10.1038/s41467-023-36004-2
TadA reprogramming to generate potent miniature base editors with high precision.
Journal: Nature communications
In common: 9 references
[5] doi:10.1172/jci196402
Base editing rescues seizures and sudden death in a SCN8A mutation-associated developmental epileptic encephalopathy model.
Journal: The Journal of clinical investigation
In common: other condition, mouse, 7 references
[6] doi:10.1126/science.adg6518 [code]
Base editing rescue of spinal muscular atrophy in cells and in mice.
Journal: Science (New York, N.Y.)
In common: other condition, mouse, 7 references
[7] doi:10.1084/jem.20220776 [code]
Vision rescue via unconstrained in vivo prime editing in degenerating neural retinas.
Journal: The Journal of experimental medicine
In common: mouse, 6 references
[8] doi:10.1038/s41591-024-03466-w [code]
In vivo base editing extends lifespan of a humanized mouse model of prion disease.
Journal: Nature medicine
In common: other condition, mouse, 6 references
[9] doi:10.1016/j.isci.2025.112355
Therapeutic restoration of miR-96 prevents hearing loss in mice through modulation of noise-induced and genetic pathways.
Journal: iScience
In common: other condition, mouse, 4 references
[10] doi:10.1016/j.ymthe.2024.03.009 [code]
In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: other condition, mouse, 5 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.